Reevaluating Anticoagulation in Antiphospholipid Syndrome: The Role of Apixaban in the Current Treatment Paradigm-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reevaluating Anticoagulation in Antiphospholipid Syndrome: The Role of Apixaban in the Current Treatment Paradigm

Published:2024-07 Issue:1 Volume:84 Page:29-31
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Galli Mattia¹²,Sciarretta Sebastiano¹³,Frati Giacomo¹³,Biondi-Zoccai Giuseppe¹⁴^ORCID

Affiliation:

1. Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy;

2. Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy;

3. IRCCS NeuroMed, Pozzilli, Italy; and

4. Cardiology Unit, Santa Maria Goretti Hospital, Latina, Italy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference13 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC;Hindricks;Eur Heart J,2020

2. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG);Humbert;Eur Heart J,2022

3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014

4. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve;Guimarães;N Engl J Med,2020

5. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation;Connolly;N Engl J Med,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations;Journal of Clinical Medicine;2024-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3